Black Rose Industries Set to Approve Q2 FY27 Results Nov 6

Black Rose Industries Ltd will consider its unaudited Q2 and first-half FY27 financial results on November 6, 2026, following a June-quarter revenue increase of 48.84% year-on-year to ₹89.08 crore and net profit growth of 147.97% to ₹10.39 crore.

What will Black Rose consider at its November 6 board meeting?

Black Rose will hold a board meeting on November 6, 2026, to consider and approve unaudited financial results for the quarter and half year ended September 30, 2026. The intimation was issued under Regulation 30 of the Securities and Exchange Board of India’s Listing Obligations and Disclosure Requirements regulations.

The company has also closed its trading window until 48 hours after the results are declared. The disclosure does not provide any Q2 FY27 revenue, profit, margin, order-book, or capital-expenditure figures ahead of the board meeting. As a result, the scheduled meeting is an announcement of the reporting date rather than a disclosure of quarterly performance.

How did Black Rose perform in the June 2026 quarter?

Black Rose reported consolidated sales of ₹89.08 crore and net profit of ₹10.39 crore for the quarter ended June 2026. Sales increased from ₹59.85 crore in the corresponding quarter of the previous year, while net profit rose from ₹4.19 crore.

The company’s reported financial summary rounded June-quarter revenue to ₹89.0 crore and profit after tax to ₹10.0 crore. On that basis, revenue was up 48.3% year-on-year and profit was up 150.0% year-on-year. The more detailed quarterly results statement showed growth of 48.84% in sales and 147.97% in net profit.

Sequentially, revenue declined 14.03% from ₹104 crore in the March 2026 quarter, according to the financial summary. However, net profit increased 10.64% quarter-on-quarter to ₹10 crore on the rounded figures. Earnings per share for the June 2026 quarter stood at ₹2.04, compared with ₹1.85 in the preceding quarter and ₹0.82 a year earlier.

Which Q2 FY27 metrics will investors watch most closely?

Investors will primarily watch whether Black Rose sustains revenue growth after its ₹89.08 crore June-quarter sales performance. The reported June-quarter operating margin was 16%, compared with 13% in the March 2026 quarter and 10% in the June 2025 quarter, making profitability an important indicator alongside sales growth.

The September-quarter result will also show whether the sequential revenue decline from ₹104 crore in March to ₹89 crore in June was temporary. The company had stated that it expected an upward trend in Q1 FY27 revenue because of higher pricing, while its stated FY27 objective was sustained growth in volumes and revenue with good overall margins.

Black Rose has not provided exact FY27 guidance for EBITDA or profit. Therefore, the announced numbers, management commentary, and any information on volumes, pricing, manufacturing and distribution will be more relevant than comparisons with an undisclosed target.

What is the financial and operating background for Black Rose?

For FY 2025-26, Black Rose reported revenue of ₹326 crore and net profit of ₹23 crore. Revenue declined 5.91% and net profit declined 15.4% from the preceding financial year, based on the provided annual financial summary. The company attributed pressure during the period to chemical price declines and geopolitical challenges, while maintaining profitability and a debt-free balance sheet.

The company operates India’s first acrylamide manufacturing plant and a polyacrylic amide manufacturing plant. Its business includes manufacturing and distribution, and earlier company commentary linked growth in its distribution division to increased volumes in core products and merchant exports.

In Q2 FY26, Black Rose had reported revenue of ₹84.31 crore, EBITDA of ₹7.54 crore and profit after tax of ₹4.43 crore. The company said then that distribution turnover had risen 60%, supported by volumes of core products and merchant exports. This operational context will help investors compare the upcoming September 2026 performance with prior quarter trends.

How does the pending result matter for shareholders and the chemical business?

The November 6 result will provide the first reported view of Black Rose’s first-half FY27 performance. It will clarify whether the sharp year-on-year increase in June-quarter sales and profit translated into continued momentum during July to September, particularly after the June quarter’s sequential decline in sales.

For shareholders, the main disclosed reference points are the June-quarter figures, including ₹2.04 earnings per share and a 16% operating margin. The company had declared a 200% interim dividend alongside its Q1 FY27 results, but the current board-meeting notice concerns only approval of unaudited Q2 and half-year results and does not disclose any proposed dividend.

The result also matters for the wider specialty chemicals and distribution ecosystem because Black Rose’s performance has been linked to pricing, volumes, manufacturing efficiency and export activity. Still, no conclusion about the September quarter can be drawn until the board approves and releases the financial statements.

Conclusion

Black Rose enters its November 6 board meeting after reporting substantial year-on-year growth in the June 2026 quarter, with revenue at ₹89.08 crore and net profit at ₹10.39 crore. The pending Q2 and half-year results will determine whether this improvement in sales, profit and operating margin continued through the September quarter.

Investors should watch the released revenue, net profit, operating margin and earnings-per-share figures, along with management’s comments on volumes, pricing, manufacturing and distribution. Black Rose has stated its aim of sustaining volume and revenue growth with good margins in FY27, but it has not issued precise profit or EBITDA guidance.